|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-0.60/-0.20
|
企業價值
292.73M
|
資產負債 |
每股賬面淨值
0.53
|
現金流量 |
現金流量率
--
|
損益表 |
收益
82.51M
|
每股收益
1.49
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/20 10:52 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
G1 Therapeutics Inc is a commercial-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat the types of cancer, such as cell lung cancer and breast cancer, and designs them to combine and enhance the anti-tumor activity of current therapies. Its product COSELA indicates to help protect bone marrow from the damage of chemotherapy. |